Bio Patrika interviews Dr. George on his thoughts about “the application of innovative technology sgRNA-Click combined with CRISPR-dCas9”

Dr. Jerrin Thomas George’s interview with Bio Patrika hosting “Vigyan Patrika”, a series of author interviews. Dr. George completed integrated MS-PhD from the IISER Pune. He pursued his doctoral research in the group of Prof. Seergazhi G. Srivastan on developing chemo-enzymatic platforms to functionalize RNA with biophysical probes using template dependent and independent polymerases. He then had a short stay as a research associate at JNCASR, Bangalore in the group of Dr. Sarit S. Agasti and now plans to join Columbia University, New York as a postdoctoral research scientist. His research interest is in the broad area of chemical biology, and molecular biophysics. For his future carrier, he is interested in deciphering the molecular mechanism of novel gene editing tools using various biophysical techniques. Jerrin published part of his PhD work titled “Terminal uridylyl transferase mediated site-directed access to clickable chromatin employing CRISPR-dCas9” as first author in Journal of the American Chemical Society (2020).

Futuristic Safe Injection System-2020

Rescitech Vision Pvt Ltd founded by a family of five members Bharati Rathore, Pratibha Rathore, Jai Hind Rathore, Dr. Bhuvan Chandra Rathore and Late Dr. Neelam Rathore in 2014. Major focus is to invent and develop a cost-effective, safe & sustainable technology for administration of drugs/vaccines. Bharati Rathore talks to Bio Patrika about their new patented invention ‘Futuristic Safe Injection System-2020’ which is now available for licensing and industrial commercialization.